Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.
Reis ES, Buonpane R, Celik H, Marty C, Lei A, Jobe F, Rupar M, Zhang Y, DiMatteo D, Awdew R, Ferreira BL, Leffet L, Lu L, Rosa E, Evrard M, Trivedi G, Wass B, Horsey A, He X, Covington M, Volgina A, Pasquier F, Legros L, Fouquet G, Vainchenker W, Yang YO, Barker B, Zhou J, Stewart S, Hitchcock IS, Dhanak D, Macarron R, Plo I, Nastri H, Mayes PA.
Reis ES, et al. Among authors: covington m.
Blood. 2024 Nov 28;144(22):2336-2348. doi: 10.1182/blood.2024024373.
Blood. 2024.
PMID: 39255409
Free article.